NR AVJR
AU anonym
AK World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations
TI WHO Expert Committee on Specifications for Pharmaceutical Preparations
QU World Health Organization Technical Report Series 2003; 908: i-viii, 1-136, back cover
PT guideline; technical report
AB This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Of particular relevance to drug regulatory authorities and pharmaceutical manufacturers, the report discusses activities related to the development of The International Pharmacopoeia and basic tests for pharmaceutical substances and dosage forms, as well as quality control of reference materials, good manufacturing practices (GMP), stability studies, inspection, hazard analysis, procurement, storage and other aspects of quality assurance of pharmaceuticals, and regulatory issues. The report is complemented by a number of annexes, including recommendations on the risk of transmitting animal spongiform encephalopathy agents via medicinal products, guidelines on GMP for pharmaceutical products, a model certificate for GMP and guidance on a GMP inspection report. The final annexes provide guidance on the application of Hazard Analysis and Critical Control Point (HACCP) method to pharmaceuticals, good storage practices and a procedure for assessing acceptability of pharmaceutical products for purchase by United Nations agencies.
MH Advisory Committees; Anti-HIV Agents/standards; Antimalarials/standards; Antitubercular Agents/standards; Drug Industry/*standards; Drug Storage/standards; Humans; International Cooperation; Pharmaceutical Preparations/classification/*standards; Pharmacopoeias/*standards; *Quality Control; *World Health Organization
SP englisch
PO Schweiz